What You Should Know:
– Current Health has partnered with Dexcom to add continuous glucose monitoring (CGM) capabilities to its remote patient monitoring (RPM) platform – enhancing care and improving outcomes for diabetics.
– Dexcom CGM data will transmit directly into the Current Health wearable and platform for review by the care management and clinical teams, improving post-discharge and chronic care of diabetes patients outside the hospital.
– Through this partnership, Current Health is now able to offer a complete view of patients’ health indicators, no matter where that patient is located – a critical need as keeping patients out of the hospital is even more important than ever with the COVID-19 pandemic. With these insights, healthcare providers are able to proactively address issues associated with diabetes and provide the best possible care.
Current Health today announced it has partnered with Dexcom to add continuous glucose monitoring (CGM) capabilities to Current Health’s AI-powered remote patient monitoring (RPM) platform. By continuously monitoring patients’ glucose levels – largely considered the fifth vital sign – the Current Health platform will empower health systems to secure actionable and comprehensive insights into overall patient health, resulting in improved patient outcomes and decreased healthcare costs.
As part of the integration, Dexcom CGM data will transmit directly into the Current Health wearable and platform for review by the care management and clinical teams, improving post-discharge and chronic care of diabetes patients outside the hospital. Dexcom and Current Health is supplied pre-configured and ready to go out of the box with a setup time of less than 5 minutes, the patient applies Dexcom and the Current Health wearable, so continuous vitals and continuous glucose are immediately available for review by the care management or clinical team. The integration will be an optional add-on for patients using the Current Health wearable, offered first to patients with diabetes. The integration will become widely available later this year.
COVID-19 Underscores Need for Continuous Glucose Monitoring
With an estimated 463 million people across the globe – or one out of every 11 adults – suffering from diabetes, health systems need insight into patients’ whole health – including glucose levels – to best manage at-risk patients. With people with diabetes particularly vulnerable to a variety of illnesses, including cardiovascular disease, nerve damage and Alzheimer’s disease – not to mention COVID-19 – healthcare providers need to be able to continuously monitor glucose levels to ensure they can proactively address issues associated with diabetes and provide the best possible care.
“Our focus has always been on delivering the best care to people with diabetes through continuous glucose monitoring,” said Matt Dolan, senior vice president and general manager of new markets at Dexcom. “By integrating our leading CGM system into Current Health’s RPM platform, we can expand the clinical utility of our technology and also offer a more comprehensive view into a patient’s whole health. These factors together mean that more patients will get the best care possible.”